comprehensive -WSS

comprehensive

author：focus 2025-09-03 03:41:36 - browse：38385

Is no one safe from the FTC? Has Pfizer bottomed out? And is biotech finally back?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we delve into the fallout over the FTC’s move to block what looked like a humdrum biotech deal between Sanofi and Maze Therapeutics, a surprising twist that leaves an unanswered question. We also discuss the latest news in the life sciences, including Pfizer’s downbeat future, Vertex Pharmaceuticals’ next big thing, and a newly minted biotech VC with a very famous name.

For more on what we cover, here’s the FTC news; here’s more from Maze Therapeutics; here’s the Pfizer news; here’s the latest on Vertex; here’s the story behind its pain drug; here’s the Reed Jobs profile; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Hyaluronic acid injections don’t help knee osteoarthritis, study finds

WSS

Ask STAT: What do you want to know about ChatGPT in medicine?

Ask STAT: What do you want to know about ChatGPT in medicine?

Why drug prescriptions should include diagnoses

What would happen to your eyes if you looked at the solar eclipse?

What would happen to your eyes if you looked at the solar eclipse?

In new study, freeze

entertainment

comprehensive

focus

Trump demands the U.S. pay no more for drugs than other countries … again

Paxlovid study fails to answer questions over benefit for broader groups

Jerome Adams on the need for new antivirals for Covid

New guidelines on severe brain injury complicate already difficult decisions

Cancer drug shortages should be causing more outrage

Our daughter's deadly disease: trisomy 18. We wanted to protect her

Novavax promises a turnaround & Lilly roils the obesity market

Colonoscopy at 40? Study finds a possible benefit

The cancer drug shortage isn’t new — and neither are the solutions

Why an extreme heat and wildfire smoke combination can be so dangerous

focus

CDC concerned about possible undetected monkeypox spread in U.K.

Why we need to separate burnout from moral injury in health care

How artificial intelligence is being used to detect, treat cancer

With FDA staff opposed to Sarepta therapy, top official intervened

White House launches permanent pandemic office

WATCH: Why do fingernails fall off when they're damaged?

Wikipedia

focus

entertainment

focus